🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, single arm study to evaluate the effic...
Status
Completed
Location
307 Hospital of PLA
Start Date
2019-06-21
Trial ID
NCT03925870
Treatments Being Tested
This is a phase II study of KN046 plus platinum-based doublet chemotherapy ...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-09-04
Trial ID
NCT04054531
Treatments Being Tested
This is an open-label, phase Ib/II, multi-center study to evaluate efficacy...
Status
Completed
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-05-30
Trial ID
NCT03872791
Treatments Being Tested
The study is an interventional Phase II clinical trial aiming to optimize i...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-10-26
Trial ID
NCT05985109
Treatments Being Tested
This study is a multicenter, randomized, double-Blind Phase III Study to co...
Status
Unknown
Location
The Second Hospital Of Anhui medical University
Start Date
2022-01-20
Trial ID
NCT05149326
This is a multicenter II study to compare KN026 and KN046 versus Oxaliplati...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-09-22
Trial ID
NCT06023758
This is an open-label, three-cohort phase 2 study of KN026 in subjects with...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2019-12-31
Trial ID
NCT04165993
Treatments Being Tested
This study is an open, multi-center clinical trial, the purpose is to study...
Status
Terminated
Location
Chinese Pla General Hospital Chinese Pla Medical School
Start Date
2021-06-07
Trial ID
NCT04601610
Treatments Being Tested
This is a phase Ib, open-label, dose-escalation and expansion study to eval...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2019-09-26
Trial ID
NCT04040699
Treatments Being Tested
Phase Ib is a dose De-escalation study to evaluate the safety, tolerability...
Status
Unknown
Location
Chi-Mei Medical Center
Start Date
2021-11-02
Trial ID
NCT04984668
Treatments Being Tested